Literature DB >> 4078667

Retinoblastoma: survival, age at detection and comparison 1914-1958, 1958-1983.

D H Abramson, R M Ellsworth, N Grumbach, F D Kitchin.   

Abstract

A retrospective analysis of the records of 1531 retinoblastoma patients (809 male, 720 female, sex of two not known) was carried out to ascertain life table survivals. Of patients seen between 1914 and 1983 survival from metastatic retinoblastoma was the same for unilateral and bilateral patients. Metastatic retinoblastoma occurred within four years from diagnosis of the unilaterally affected patients and within nine years from diagnosis of the bilaterally affected patients. Survival thereafter remained at 76%. Because of the development of second non-ocular tumors in survivors of bilateral retinoblastoma there was a dramatic difference between survival of the patient with unilateral and bilateral disease. Within five years after diagnosis of bilateral retinoblastoma more children die from their second tumor than retinoblastoma itself. By 25 years after diagnosis more than 50% of the bilaterally affected children are dead and by 35 years 59% are dead. There was no difference between survival of boys and girls. Although bilateral patients were seen at significantly lower ages at diagnosis, they did not have a lower mortality rate from metastatic retinoblastoma. Despite the fact that bilaterally affected children with a family history were diagnosed at a younger age than those without a family history (11 vs. 15 mos.) mortality from metastatic retinoblastoma was the same. Similarly, even though unilateral patients with a family history were diagnosed younger than those without a family history (5 vs. 25 mos.) mortality from metastatic retinoblastoma was the same. There has been little change in the age at detection for retinoblastoma in the pre- versus post-1958 series and no change in survival rate for bilateral or unilateral patients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1985        PMID: 4078667     DOI: 10.3928/0191-3913-19851101-11

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  10 in total

Review 1.  The diagnosis of retinoblastoma.

Authors:  D H Abramson
Journal:  Bull N Y Acad Med       Date:  1988-05

2.  Characteristics and clinical presentations of pediatric retinoblastoma in North-western Iran.

Authors:  Reza Nabie; Nazli Taheri; Ali Mahdavi Fard; Rohollah Fadaei Fouladi
Journal:  Int J Ophthalmol       Date:  2012-08-18       Impact factor: 1.779

3.  Parents with unilateral retinoblastoma: their affected children.

Authors:  C M Notis; K Niksarli; D H Abramson; A R DeLillo; R M Ellsworth
Journal:  Br J Ophthalmol       Date:  1996-03       Impact factor: 4.638

4.  Unilateral retinoblastoma: new intraocular tumours after treatment.

Authors:  D H Abramson; L S Gamell; R M Ellsworth; E F Kruger; C A Servodidio; L Turner; D Sussman
Journal:  Br J Ophthalmol       Date:  1994-09       Impact factor: 4.638

5.  Retinoblastoma treatment burden and economic cost: impact of age at diagnosis and selection of primary therapy.

Authors:  Hassan A Aziz; Charlotte E Lasenna; Michael Vigoda; Cristina Fernandes; William Feuer; Mohammed Ali Aziz-Sultan; Timothy G Murray
Journal:  Clin Ophthalmol       Date:  2012-10-04

6.  Retinoblastoma in adults: a case report and literature review.

Authors:  Mehdi Sharifzadeh; Fariba Ghassemi; Fahimeh Asadi Amoli; Elham Rahmanikhah; Seid Zia Tabatabaie
Journal:  J Ophthalmic Vis Res       Date:  2014 Jul-Sep

Review 7.  Adult onset retinoblastoma.

Authors:  Sabyasachi Sengupta; Utsab Pan; Vikas Khetan
Journal:  Indian J Ophthalmol       Date:  2016-07       Impact factor: 1.848

8.  Efficacy and safety of aflibercept in in vitro and in vivo models of retinoblastoma.

Authors:  Dong Yoon Kim; Jeong A Choi; Jae-Young Koh; Young Hee Yoon
Journal:  J Exp Clin Cancer Res       Date:  2016-11-04

9.  Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma.

Authors:  Anderson H Webb; Bradley T Gao; Zachary K Goldsmith; Andrew S Irvine; Nabil Saleh; Ryan P Lee; Justin B Lendermon; Rajini Bheemreddy; Qiuhua Zhang; Rachel C Brennan; Dianna Johnson; Jena J Steinle; Matthew W Wilson; Vanessa M Morales-Tirado
Journal:  BMC Cancer       Date:  2017-06-20       Impact factor: 4.430

10.  Inhibiting the Progression of Human Retinoblastoma Cell by Downregulation of MMP-2/MMP-9 Using Short Hairpin RNAs (shRNAs) In Vitro.

Authors:  Nana Meng; Zhi Zhao; Chunhe Shi; Leizhou Xia
Journal:  J Ophthalmol       Date:  2020-05-13       Impact factor: 1.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.